PIP4K2C and viral infectious disease: Beyond viral infections, further development of RMC-113 and/or other PIP4K2C inhibitors may have implications for the treatment of non-infectious conditions in which PIP4K2C is implicated, including Huntington’s disease17, 18, 63.